Author: Ken Dropiewski

BioSig Technologies Completes Private Placement

Santa Monica, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company closed a private placement of $4,281,000. Combined with the […]

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

WINNIPEG, Aug. 13, 2018 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce that the United States Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) single dose vial (“SNP”), […]

Advanced Cardiac Therapeutics, Inc. Changes Name to EPIX Therapeutics, Inc.

SANTA CLARA, Calif., Aug. 13, 2018 /PRNewswire/ — Advanced Cardiac Therapeutics, Inc. (ACT), a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AFIB), today announced it has changed its name to EPIX Therapeutics, Inc. Founded in 2007, the company has pioneered the development […]

ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., Aug. 09, 2018 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported financial results for the quarter ended June 30, 2018. “The second quarter of this year saw an important milestone for the […]

BioCardia, Inc. Reports Second Quarter 2018 Financial Results and Business Highlights

SAN CARLOS, Calif., Aug. 9, 2018 /PRNewswire/ — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the second quarter 2018 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2018 with […]

NuCryo Vascular Announces Commercialization Agreement with Lokai Medical for Innovative Treatment for Peripheral Arterial Disease

SAN JOSE, Calif.–(BUSINESS WIRE)–NuCryo Vascular today announced that the company has signed a commercialization agreement with Lokai Medical, a specialty distributor of coronary/peripheral and interventional devices, to distribute the PolarCath™ Balloon Dilatation System in the United States. Balloon Cryoplasty® has been shown in clinical studies and in everyday procedures to be […]

Garmin® Health and Cardiogram announce integration of Cardiogram Heart Health app and Garmin wearables

OLATHE, Kan.–(BUSINESS WIRE)–Garmin International, Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), today announced that the Cardiogram heart health app is now compatible with all Garmin wearables featuring optical heart rate, including many of the latest fēnix®, Forerunner®, and vívo series devices. The Cardiogram app provides advanced insights based on […]

Hancock Jaffe Laboratories Receives Medical Research Committee Approval for First-in-Human VenoValve Study

IRVINE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in bioprosthetic medical devices that establish improved standards of care for treating cardiac and vascular diseases, today announced that it has received approval for the first-in-human testing of its VenoValve® bioprosthetic medical […]

Cardiometabolic Health Congress Presents Senior Planning Committee & Chairs

Boca Raton, Florida, Aug. 09, 2018 (GLOBE NEWSWIRE) — CMHC is proud to announce its finalized Senior Planning Committee & Chairpersons for the 2018-2019 season. CMHC has cultivated a groundbreaking educational planning team, with world-renowned professors, clinicians, and researchers: all of whom will help deliver the most current, clinically accurate, and scientifically […]